Insider · CIK 0001856094

Borgeson Blake

CIK 0001856094 Name as filed on the most recent filing

Filed as Borgeson Blake (65)

71 transaction lines · from 65 filings · filed 2021-11-22 to 2026-08-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

71 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2023-05-30 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 78,134, disposed Open Form 4 filing 0001209191-23-033391
2023-05-16 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 45,241, disposed Open Form 4 filing 0001209191-23-030383
2023-04-18 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 52,730, disposed Open Form 4 filing 0001209191-23-025026
2023-04-04 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 57,992, disposed Open Form 4 filing 0001209191-23-023625
2023-03-21 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 65,744, disposed Open Form 4 filing 0001209191-23-020799
2023-03-07 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 73,989, disposed Open Form 4 filing 0001209191-23-017619
2023-02-21 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 68,708, disposed Open Form 4 filing 0001209191-23-012321
2023-02-07 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 78,263, disposed Open Form 4 filing 0001209191-23-008051
2023-01-24 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 77,368, disposed Open Form 4 filing 0001209191-23-005098
2023-01-10 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 68,283, disposed Open Form 4 filing 0001209191-23-003180
2022-12-27 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 64,373, disposed Open Form 4 filing 0001209191-22-062940
2022-12-13 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 79,598, disposed Open Form 4 filing 0001209191-22-061487
2022-11-29 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 77,786, disposed Open Form 4 filing 0001209191-22-059213
2022-11-16 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 197,610, disposed Open Form 4 filing 0001209191-22-057958
2022-01-04 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 173,528, disposed Open Form 4 filing 0001209191-22-002048
2021-12-21 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 180,478, disposed Open Form 4 filing 0001209191-21-071103
2021-12-07 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 3 lines 195,533, disposed Open Form 4 filing 0001209191-21-068920
2021-11-18 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 2 lines 182,005, disposed Open Form 4 filing 0001209191-21-066254

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 71
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Borgeson Blake, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001856094

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.